CN Stock MarketDetailed Quotes

688193 Shanghai Rendu Biotechnology

Watchlist
  • 42.38
  • -0.54-1.26%
Market Closed Nov 29 15:00 CST
1.70BMarket Cap79.66P/E (TTM)

Shanghai Rendu Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
11.57%130.64M
8.31%86.68M
15.60%44.82M
-45.89%164.41M
-51.23%117.1M
-52.83%80.03M
-58.44%38.77M
3.95%303.85M
7.40%240.1M
21.07%169.66M
Operating revenue
11.57%130.64M
8.31%86.68M
15.60%44.82M
-45.89%164.41M
-51.23%117.1M
-52.83%80.03M
-58.44%38.77M
3.95%303.85M
7.40%240.1M
21.07%169.66M
Total operating cost
0.76%135.83M
-9.07%88.42M
-9.55%43.74M
-37.24%182.29M
-38.98%134.81M
-33.94%97.24M
-33.93%48.36M
27.94%290.47M
31.90%220.91M
43.15%147.2M
Operating cost
19.67%25.62M
10.65%16.42M
14.80%8.71M
-70.77%30.61M
-70.79%21.41M
-72.62%14.84M
-73.63%7.59M
41.20%104.74M
34.30%73.28M
65.48%54.2M
Operating tax surcharges
5.51%739.81K
5.12%493.8K
12.38%244.78K
-19.63%965.11K
-18.96%701.2K
-31.80%469.75K
-53.98%217.82K
44.87%1.2M
54.11%865.28K
82.43%688.77K
Operating expense
-6.42%63.48M
-19.55%41.48M
-22.37%20.26M
-26.30%90.95M
-32.78%67.84M
-21.76%51.55M
-14.12%26.09M
21.72%123.4M
30.82%100.91M
39.76%65.89M
Administration expense
2.92%21.66M
-3.52%13.99M
1.24%7.22M
-14.58%26.77M
-7.43%21.04M
7.90%14.5M
8.74%7.14M
21.38%31.34M
23.35%22.73M
6.90%13.44M
Financial expense
3.86%-5.66M
-70.10%-4.65M
-140.18%-2.87M
-84.95%-8.14M
-98.22%-5.89M
-61.20%-2.73M
-334.26%-1.2M
-197.77%-4.4M
-130.46%-2.97M
-123.61%-1.69M
-Interest expense (Financial expense)
-53.71%188.57K
-46.00%161.84K
-15.07%110.23K
21.30%431.2K
255.18%407.4K
51.28%299.69K
74.85%129.79K
--355.47K
-47.70%114.7K
12.65%198.11K
-Interest Income (Financial expense)
-6.25%-5.95M
-59.15%-4.84M
-88.67%-2.56M
-106.18%-8.72M
-124.06%-5.6M
-54.72%-3.04M
-478.35%-1.35M
---4.23M
-50.68%-2.5M
-80.11%-1.97M
Research and development
0.98%30M
11.19%20.68M
19.46%10.18M
20.31%41.14M
13.87%29.7M
26.76%18.6M
17.21%8.52M
29.91%34.19M
44.30%26.09M
36.66%14.67M
Credit Impairment Loss
49.29%-118.23K
-22.02%-268.51K
-34.53%-425.49K
77.16%-629.91K
87.29%-233.15K
89.92%-220.06K
42.94%-316.27K
-149.72%-2.76M
-63.81%-1.83M
-653.37%-2.18M
Asset Impairment Loss
-125.46%-1.93M
-70.43%-1.13M
33.48%-357.33K
49.82%-1.28M
-9.53%-853.9K
-72.86%-664.93K
-81.62%-537.19K
-1,177.57%-2.54M
-546.20%-779.62K
-241.29%-384.66K
Adjustment items of total operating cost
----
----
----
----
--0.01
---0.01
----
----
----
----
Other net revenue
Fair value change income
1,191.95%3.66M
139.04%1.56M
189.78%620.81K
-32.39%661.64K
---335.36K
--651.77K
---691.48K
--978.61K
----
----
Invest income
-45.12%3.62M
-30.20%2.31M
-65.78%974.19K
-17.01%6.92M
-5.07%6.59M
-2.05%3.31M
287.18%2.85M
586.95%8.34M
941.16%6.94M
687.39%3.38M
Asset deal income
----
----
----
-138.54%-53.51K
-139.90%-53.51K
----
----
-81.79%138.85K
-64.31%134.12K
213.33%89.9K
Other revenue
241.15%4.46M
144.44%3.19M
1,204.55%1.49M
77.46%17.69M
-81.31%1.31M
-47.49%1.31M
--113.93K
59.49%9.97M
304.66%6.99M
687.24%2.49M
Adjusted Items effecting operating profit
----
----
---0.01
----
----
----
----
----
----
----
Operating profit
139.91%4.5M
130.62%3.92M
141.26%3.37M
-80.22%5.44M
-136.83%-11.28M
-149.59%-12.82M
-140.76%-8.18M
-61.90%27.51M
-46.81%30.64M
-31.38%25.85M
Add:Non operating Income
12,267,206.21%177.88K
2,975,650.45%33.03K
--33.03K
3,197.41%135.38K
-99.97%1.45
-99.98%1.11
----
-99.35%4.11K
-99.17%5.35K
-99.16%5.35K
Less:Non operating expense
-61.02%193.1K
-6.33%140.76K
-77.32%33.61K
-1.77%815.06K
-40.24%495.38K
-50.58%150.27K
--148.21K
116.82%829.73K
127.11%828.99K
-11.18%304.06K
Total profit
138.10%4.49M
129.43%3.82M
140.52%3.37M
-82.15%4.76M
-139.51%-11.78M
-150.75%-12.97M
-141.49%-8.32M
-63.17%26.68M
-48.49%29.82M
-32.71%25.55M
Less:Income tax cost
94.67%-183.11K
81.48%-513.99K
82.88%-330.77K
-204.38%-3.5M
-156.69%-3.44M
-176.47%-2.78M
-159.29%-1.93M
-57.17%3.35M
-8.99%6.06M
-26.44%3.63M
Add:Adjusted items effecting net profit
----
----
----
----
--0.01
----
----
----
----
----
Net profit
155.99%4.67M
142.49%4.33M
157.94%3.7M
-64.60%8.26M
-135.12%-8.34M
-146.50%-10.19M
-138.03%-6.39M
-63.89%23.33M
-53.62%23.75M
-33.64%21.92M
Net profit from continuing operation
155.99%4.67M
142.49%4.33M
157.94%3.7M
-64.60%8.26M
-135.12%-8.34M
-146.50%-10.19M
-138.03%-6.39M
-63.89%23.33M
-53.62%23.75M
-33.64%21.92M
Net profit of parent company owners
155.99%4.67M
142.49%4.33M
157.94%3.7M
-64.60%8.26M
-135.12%-8.34M
-146.50%-10.19M
-138.03%-6.39M
-63.89%23.33M
-53.62%23.75M
-33.64%21.92M
Earning per share
Basic earning per share
157.14%0.12
148.00%0.12
156.25%0.09
-66.13%0.21
-129.58%-0.21
-139.68%-0.25
-128.57%-0.16
-71.16%0.62
-58.48%0.71
-42.73%0.63
Diluted earning per share
157.14%0.12
148.00%0.12
156.25%0.09
-60.66%0.24
-130.00%-0.21
-140.32%-0.25
-128.57%-0.16
-71.36%0.61
-58.82%0.7
-43.12%0.62
Other composite income
-134.48%-414.68K
-83.84%244.72K
113.29%68.68K
228.55%621.35K
42.82%1.2M
279.64%1.51M
-2,184.58%-516.67K
-219.53%-483.37K
2,320.36%842.14K
768.15%399K
Other composite income of parent company owners
-134.48%-414.68K
-83.84%244.72K
113.29%68.68K
228.55%621.35K
42.82%1.2M
279.64%1.51M
-2,184.58%-516.67K
-219.53%-483.37K
2,320.36%842.14K
768.15%399K
Total composite income
159.61%4.26M
152.73%4.58M
154.60%3.77M
-61.13%8.88M
-129.03%-7.14M
-138.88%-8.68M
-141.16%-6.91M
-64.56%22.85M
-51.94%24.6M
-32.31%22.32M
Total composite income of parent company owners
159.61%4.26M
152.73%4.58M
154.60%3.77M
-61.13%8.88M
-129.03%-7.14M
-138.88%-8.68M
-141.16%-6.91M
-64.56%22.85M
-51.94%24.6M
-32.31%22.32M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
--
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 11.57%130.64M8.31%86.68M15.60%44.82M-45.89%164.41M-51.23%117.1M-52.83%80.03M-58.44%38.77M3.95%303.85M7.40%240.1M21.07%169.66M
Operating revenue 11.57%130.64M8.31%86.68M15.60%44.82M-45.89%164.41M-51.23%117.1M-52.83%80.03M-58.44%38.77M3.95%303.85M7.40%240.1M21.07%169.66M
Total operating cost 0.76%135.83M-9.07%88.42M-9.55%43.74M-37.24%182.29M-38.98%134.81M-33.94%97.24M-33.93%48.36M27.94%290.47M31.90%220.91M43.15%147.2M
Operating cost 19.67%25.62M10.65%16.42M14.80%8.71M-70.77%30.61M-70.79%21.41M-72.62%14.84M-73.63%7.59M41.20%104.74M34.30%73.28M65.48%54.2M
Operating tax surcharges 5.51%739.81K5.12%493.8K12.38%244.78K-19.63%965.11K-18.96%701.2K-31.80%469.75K-53.98%217.82K44.87%1.2M54.11%865.28K82.43%688.77K
Operating expense -6.42%63.48M-19.55%41.48M-22.37%20.26M-26.30%90.95M-32.78%67.84M-21.76%51.55M-14.12%26.09M21.72%123.4M30.82%100.91M39.76%65.89M
Administration expense 2.92%21.66M-3.52%13.99M1.24%7.22M-14.58%26.77M-7.43%21.04M7.90%14.5M8.74%7.14M21.38%31.34M23.35%22.73M6.90%13.44M
Financial expense 3.86%-5.66M-70.10%-4.65M-140.18%-2.87M-84.95%-8.14M-98.22%-5.89M-61.20%-2.73M-334.26%-1.2M-197.77%-4.4M-130.46%-2.97M-123.61%-1.69M
-Interest expense (Financial expense) -53.71%188.57K-46.00%161.84K-15.07%110.23K21.30%431.2K255.18%407.4K51.28%299.69K74.85%129.79K--355.47K-47.70%114.7K12.65%198.11K
-Interest Income (Financial expense) -6.25%-5.95M-59.15%-4.84M-88.67%-2.56M-106.18%-8.72M-124.06%-5.6M-54.72%-3.04M-478.35%-1.35M---4.23M-50.68%-2.5M-80.11%-1.97M
Research and development 0.98%30M11.19%20.68M19.46%10.18M20.31%41.14M13.87%29.7M26.76%18.6M17.21%8.52M29.91%34.19M44.30%26.09M36.66%14.67M
Credit Impairment Loss 49.29%-118.23K-22.02%-268.51K-34.53%-425.49K77.16%-629.91K87.29%-233.15K89.92%-220.06K42.94%-316.27K-149.72%-2.76M-63.81%-1.83M-653.37%-2.18M
Asset Impairment Loss -125.46%-1.93M-70.43%-1.13M33.48%-357.33K49.82%-1.28M-9.53%-853.9K-72.86%-664.93K-81.62%-537.19K-1,177.57%-2.54M-546.20%-779.62K-241.29%-384.66K
Adjustment items of total operating cost ------------------0.01---0.01----------------
Other net revenue
Fair value change income 1,191.95%3.66M139.04%1.56M189.78%620.81K-32.39%661.64K---335.36K--651.77K---691.48K--978.61K--------
Invest income -45.12%3.62M-30.20%2.31M-65.78%974.19K-17.01%6.92M-5.07%6.59M-2.05%3.31M287.18%2.85M586.95%8.34M941.16%6.94M687.39%3.38M
Asset deal income -------------138.54%-53.51K-139.90%-53.51K---------81.79%138.85K-64.31%134.12K213.33%89.9K
Other revenue 241.15%4.46M144.44%3.19M1,204.55%1.49M77.46%17.69M-81.31%1.31M-47.49%1.31M--113.93K59.49%9.97M304.66%6.99M687.24%2.49M
Adjusted Items effecting operating profit -----------0.01----------------------------
Operating profit 139.91%4.5M130.62%3.92M141.26%3.37M-80.22%5.44M-136.83%-11.28M-149.59%-12.82M-140.76%-8.18M-61.90%27.51M-46.81%30.64M-31.38%25.85M
Add:Non operating Income 12,267,206.21%177.88K2,975,650.45%33.03K--33.03K3,197.41%135.38K-99.97%1.45-99.98%1.11-----99.35%4.11K-99.17%5.35K-99.16%5.35K
Less:Non operating expense -61.02%193.1K-6.33%140.76K-77.32%33.61K-1.77%815.06K-40.24%495.38K-50.58%150.27K--148.21K116.82%829.73K127.11%828.99K-11.18%304.06K
Total profit 138.10%4.49M129.43%3.82M140.52%3.37M-82.15%4.76M-139.51%-11.78M-150.75%-12.97M-141.49%-8.32M-63.17%26.68M-48.49%29.82M-32.71%25.55M
Less:Income tax cost 94.67%-183.11K81.48%-513.99K82.88%-330.77K-204.38%-3.5M-156.69%-3.44M-176.47%-2.78M-159.29%-1.93M-57.17%3.35M-8.99%6.06M-26.44%3.63M
Add:Adjusted items effecting net profit ------------------0.01--------------------
Net profit 155.99%4.67M142.49%4.33M157.94%3.7M-64.60%8.26M-135.12%-8.34M-146.50%-10.19M-138.03%-6.39M-63.89%23.33M-53.62%23.75M-33.64%21.92M
Net profit from continuing operation 155.99%4.67M142.49%4.33M157.94%3.7M-64.60%8.26M-135.12%-8.34M-146.50%-10.19M-138.03%-6.39M-63.89%23.33M-53.62%23.75M-33.64%21.92M
Net profit of parent company owners 155.99%4.67M142.49%4.33M157.94%3.7M-64.60%8.26M-135.12%-8.34M-146.50%-10.19M-138.03%-6.39M-63.89%23.33M-53.62%23.75M-33.64%21.92M
Earning per share
Basic earning per share 157.14%0.12148.00%0.12156.25%0.09-66.13%0.21-129.58%-0.21-139.68%-0.25-128.57%-0.16-71.16%0.62-58.48%0.71-42.73%0.63
Diluted earning per share 157.14%0.12148.00%0.12156.25%0.09-60.66%0.24-130.00%-0.21-140.32%-0.25-128.57%-0.16-71.36%0.61-58.82%0.7-43.12%0.62
Other composite income -134.48%-414.68K-83.84%244.72K113.29%68.68K228.55%621.35K42.82%1.2M279.64%1.51M-2,184.58%-516.67K-219.53%-483.37K2,320.36%842.14K768.15%399K
Other composite income of parent company owners -134.48%-414.68K-83.84%244.72K113.29%68.68K228.55%621.35K42.82%1.2M279.64%1.51M-2,184.58%-516.67K-219.53%-483.37K2,320.36%842.14K768.15%399K
Total composite income 159.61%4.26M152.73%4.58M154.60%3.77M-61.13%8.88M-129.03%-7.14M-138.88%-8.68M-141.16%-6.91M-64.56%22.85M-51.94%24.6M-32.31%22.32M
Total composite income of parent company owners 159.61%4.26M152.73%4.58M154.60%3.77M-61.13%8.88M-129.03%-7.14M-138.88%-8.68M-141.16%-6.91M-64.56%22.85M-51.94%24.6M-32.31%22.32M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------------
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data